Leichong Chen

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Integrating Single-Cell, Bulk, and Spatial Transcriptomics Unveils a Novel Ribosome Biogenesis-Related Prognostic Model and Defines RPS19BP1 as a Pro-Oncogenic Regulator in Lung Adenocarcinoma.

Integrating Single-Cell, Bulk, and Spatial Transcriptomics Unveils a Novel Ribosome Biogenesis-Related Prognostic Model and Defines RPS19BP1 as a Pro-Oncogenic Regulator in Lung Adenocarcinoma.

Journal: International journal of molecular sciences
Published: May 23, 2026

Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockade.

Inhibition of protein kinase CK2 remodels the tumor immune microenvironment and sensitizes lung cancer to PD-L1 blockade.

Journal: Experimental hematology & oncology
Published: October 28, 2025

Durable response to immunotherapy in NSCLC with duodenal metastasis.

Durable response to immunotherapy in NSCLC with duodenal metastasis.

Journal: Discover oncology
Published: June 25, 2025

Global research landscape on artificial intelligence in echocardiography from 1997 to 2024: Bibliometric analysis.

Global research landscape on artificial intelligence in echocardiography from 1997 to 2024: Bibliometric analysis.

Journal: Digital health
Published: December 30, 2024

Small cell conversion complicated with hypertrophic pulmonary osteoarthropathy after targeted therapy for advanced EGFR-mutated lung adenocarcinoma: A case report.

Small cell conversion complicated with hypertrophic pulmonary osteoarthropathy after targeted therapy for advanced EGFR-mutated lung adenocarcinoma: A case report.

Journal: Indian journal of pathology & microbiology
Published: February 15, 2024

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome.

Concomitant ALK Fusion and TP53/EGFR Mutation Lead to Adverse Prognostic Outcome.

Journal: The clinical respiratory journal
Published: February 06, 2024

Protein kinase CK2: An emerging regulator of cellular metabolism.

Protein kinase CK2: An emerging regulator of cellular metabolism.

Journal: BioFactors (Oxford, England)
Published: August 21, 2023

Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases.

Long-term survival after stereotactic body radiotherapy combined with immunotherapy plus anti-angiogenesis therapy in patients with advanced non-small cell lung cancer and EGFR exon 20 insertion mutation: a report of two cases.

Journal: Translational lung cancer research
Published: August 21, 2023

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics.

The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics.

Journal: Discover oncology
Published: April 05, 2023

An unusual ectopic thymoma clonal evolution analysis: A case report.

An unusual ectopic thymoma clonal evolution analysis: A case report.

Journal: Open life sciences
Published: December 04, 2022

Emerging role of Protein Kinase CK2 in Tumor immunity.

Emerging role of Protein Kinase CK2 in Tumor immunity.

Journal: Frontiers in oncology
Published: October 09, 2022

Research progress of tumor-derived extracellular vesicles in the treatment of malignant pleural effusion.

Research progress of tumor-derived extracellular vesicles in the treatment of malignant pleural effusion.

Journal: Cancer medicine
Published: April 07, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026